Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Leukemia

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 7522296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing

  2024cites this paper
• Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance

  2024cites this paper
• Update on diagnosis and treatment of Chronic Lymphocytic Leukemia (CLL)

  2023cites this paper
• Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner

  2019cites this paper
• Epidemiology and Clinical Profile of Patients with Chronic Lymphocytic Leukaemia in a Tertiary Hospital in Nigeria

  2019cites this paper
• UNIVERSITY OF CALIFORNIA, SAN DIEGO 14-3-3zeta mediates the recruitment of ARHGEF2 onto ROR1 to facilitate Wnt5a- induced CLL proliferation/migration A Thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Biology by

  2016cites this paper
• Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites

  2015cites this paper
• B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA-ASSOCIATED NUCLEAR ANTIGENS

  2015cites this paper
• Midkine as a regulator of B cell survival in health and disease

  2014cites this paper
• PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.

  2014cites this paper
• The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.

  2012cites this paper
• R‐roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase‐dependent apoptosis

  2010cites this paper
• New parameters of diploid histogram of image DNA cytometry and newly characterized types of nucleolar organizer region structures in defining the proliferative-kinetic index in chronic leukemic lymphoproliferative disorders.

  2009cites this paper
• Novel potent pharmacological cyclin-dependent kinase inhibitors.

  2009cites this paper
• In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone.

  2006cites this paper
• Changes in leukemic cell nuclei revealed by differential scanning calorimetry

  2005cites this paper
• 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo.

  2004cites this paper
• Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells.

  2004cites this paper
• Production of intracellular IL‐2, TNF‐α, and IFN‐γ by T cells in B‐CLL

  2003cites this paper
• Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.

  2003cites this paper
• Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.

  2002cites this paper
• In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia

  2002cites this paper
• Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia

  2002cites this paper
• Hydroxychloroquine-induced Apoptosis of Chronic Lymphocytic Leukemia Involves Activation of Caspase-3 and Modulation of Bcl-2/bax/ratio

  2002cites this paper
• Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia

  2002cites this paper
• Prognostic value of plasma interleukin‐6 levels in patients with chronic lymphocytic leukemia

  2002cites this paper
• Early induction of apoptosis in B‐chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase‐3 and no protection by survival factors

  2001cites this paper
• Doxorubicin and a butyric acid derivative effectively reduce levels of BCL‐2 protein
in the cells of chronic lymphocytic
leukemia patient

  2001cites this paper
• Significance of p53 mutations in patients with chronic lymphocytic leukemia

  2001influential citation
• Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis

  2001cites this paper
• Chronic Lymphoproliferative Disorders: An Integrated Point of View for the Differential Diagnosis

  2000cites this paper
• Expression of bcl‐2 and bax in cellsisolated from B‐chronic lymphocytic leukemia patients at differentstages of the disease

  2000cites this paper
• Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia.

  1999cites this paper
• Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia.

  1999cites this paper
• Blood‐soluble Fas/APO‐1 (CD95) in chronic lymphocytic leukemia

  1999cites this paper
• Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells.

  1998cites this paper
• Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.

  1998cites this paper
• Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.

  1998cites this paper
• Diminished production of interleukin‐6 in chronic lymphocytic leukaemia (B‐CLL) cells from patients at advanced stages of disease

  1998cites this paper
• Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B‐chronic lymphocytic leukaemia cells

  1998cites this paper
• Proto-oncogene expression in bovine peripheral blood leukemic lymphocytes during their spontaneous proliferation, differentiation and apoptosis in vitro.

  1998cites this paper
• Overexpanded B cell clone mediating leukemic arthritis by abundant secretion of interleukin-1beta: a case report.

  1998cites this paper
• Kinetics of chlorambucil in vitro: effects of fluid matrix, human gastric juice, plasma proteins and red cells.

  1997cites this paper
• Chronic lymphocytic leukemia of B-cell origin: oral manifestations and dental treatment planning.

  1997cites this paper
• Chronic Lymphocytic Leukemia: An Update on Current Treatment Approaches.

  1997cites this paper
• Functional aspects of apoptosis in hematopoiesis and consequences of failure.

  1997cites this paper
• Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?

  1997cites this paper
• B-cell chronic lymphocytic leukemia: recent progress in biology, diagnosis, and therapy.

  1997cites this paper
• The low-grade lymphoproliferative disorders.

  1997cites this paper
• CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.

  1997cites this paper
• Induction of apoptosis by 2-chlorodeoxyadenosine in B cell chronic lymphocytic leukemia

  1997cites this paper
• Prognostic factors in chronic lymphocytic leukemia.

  1997cites this paper
• Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells.

  1997cites this paper
• Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocytic leukaemia

  1996cites this paper
• Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.

  1996cites this paper
• Acquired factor VIII inhibitor at the onset of prolymphocytic leukemia.

  1996cites this paper
• Expression of an oncofetal 65-kDa phosphoprotein in lymphocytic and granulocytic leukemias.

  1996cites this paper
• Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.

  1995cites this paper
• Chronic lymphocytic leukemia.

  1995cites this paper
• Chronic lymphocytic leukemia: present status.

  1995cites this paper